Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Joint statement by members of the NCCN Prostate Cancer Guidelines Panel.

Mohler JL; NCCN Prostate Cancer Panel..

J Natl Compr Canc Netw. 2013 Nov;11(11):1310-2. No abstract available.

PMID:
24225965
2.

Intensity-modulated radiation therapy for prostate cancer.

Jacobs BL, Schroeck FR, Hollenbeck BK.

N Engl J Med. 2014 Feb 13;370(7):679. doi: 10.1056/NEJMc1314524#SA2. No abstract available.

PMID:
24521127
3.

Intensity-modulated radiation therapy for prostate cancer.

Sartor O, Silberstein JL.

N Engl J Med. 2014 Feb 13;370(7):679. doi: 10.1056/NEJMc1314524#SA1. No abstract available.

PMID:
24521126
4.

Intensity-modulated radiation therapy for prostate cancer.

Mitchell JM.

N Engl J Med. 2014 Feb 13;370(7):679-80. doi: 10.1056/NEJMc1314524. No abstract available.

5.

Re: urologists' use of intensity-modulated radiation therapy for prostate cancer.

Penson DF.

J Urol. 2014 May;191(5):1292. doi: 10.1016/j.juro.2014.02.071. Epub 2014 Feb 22. No abstract available.

PMID:
24745495
6.

Prostate cancer: IMRT treatment rates increase with urologist self-referral.

Phillips R.

Nat Rev Urol. 2013 Dec;10(12):680. doi: 10.1038/nrurol.2013.256. Epub 2013 Nov 12. No abstract available.

PMID:
24217677
7.

Urologists' use of intensity-modulated radiation therapy for prostate cancer.

Mitchell JM.

N Engl J Med. 2013 Oct 24;369(17):1629-37. doi: 10.1056/NEJMsa1201141.

8.

Response to "Integrated prostate cancer centers and overutilization of IMRT: a close look at fee-for-service medicine in radiation oncology." (Int J Radiat Oncol Biol Phys 2010;78:1285-1288).

Zimberg SH, Olsson CA.

Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1607; author reply 1607-8. doi: 10.1016/j.ijrobp.2010.07.1998. No abstract available.

PMID:
21092840
9.

Integrated prostate cancer centers and over-utilization of IMRT: a close look at fee-for-service medicine in radiation oncology.

Falit BP, Gross CP, Roberts KB.

Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1285-8. doi: 10.1016/j.ijrobp.2009.10.060. No abstract available.

PMID:
20338470
10.

US urology clinics overprescribe prostate radiotherapy.

Furlow B.

Lancet Oncol. 2011 Feb;12(2):122. No abstract available.

PMID:
21355130
11.

Formation of combined urology and radiation oncology practices: objective data from radiation oncologists for rationale.

Schilling PJ.

Am J Clin Oncol. 2011 Jun;34(3):289-91. doi: 10.1097/COC.0b013e3181e1cac4.

PMID:
20805740
12.

Adhering to the standard of care for prostate cancer.

Kapoor DA, Penson D.

Health Aff (Millwood). 2012 Jun;31(6):1367; author reply 1367. doi: 10.1377/hlthaff.2012.0478. No abstract available.

13.

Integrated prostate cancer centers and over-utilization of IMRT: In regard to Falit et al. (Int J Radiat Oncol Biol Phys 2010;76:1285-1288).

Rickles DJ.

Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1280; author reply 1280-1. doi: 10.1016/j.ijrobp.2010.09.063. No abstract available.

PMID:
21353167
14.

Changes in urology standard of care.

Plandowski JW.

Health Aff (Millwood). 2012 Jun;31(6):1367; author reply 1367. doi: 10.1377/hlthaff.2012.0477. No abstract available.

15.

Financial gain is driving referrals for specialist prostate radiotherapy, says report.

McCarthy M.

BMJ. 2013 Aug 8;347:f4978. doi: 10.1136/bmj.f4978. No abstract available.

PMID:
23929905
16.

The right therapy for prostate cancer.

Rose CM.

Health Aff (Millwood). 2012 Jul;31(7):1648; author reply 1649. doi: 10.1377/hlthaff.2012.0625. No abstract available.

17.

Re: use of advanced treatment technologies among men at low risk of dying from prostate cancer.

See WA.

Eur Urol. 2014 Jan;65(1):250. doi: 10.1016/j.eururo.2013.10.024. No abstract available.

PMID:
24289855
18.

The paradox of multidisciplinary care.

Potters L.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):20-2. doi: 10.1016/j.ijrobp.2012.07.007. No abstract available.

PMID:
22901419
19.

Use of advanced treatment technologies among men at low risk of dying from prostate cancer.

Sammon JD, Trinh QD, Menon M.

BJU Int. 2014 Aug;114(2):166-7. doi: 10.1111/bju.12547. Epub 2014 Mar 14. No abstract available.

20.

Urologists' self-referral for pathology of biopsy specimens linked to increased use and lower prostate cancer detection.

Mitchell JM.

Health Aff (Millwood). 2012 Apr;31(4):741-9. doi: 10.1377/hlthaff.2011.1372.

Supplemental Content

Support Center